Search

everythinglearnresearchcommunity

for

Search:↓

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Mutations in the spike protein affect drug binding and effectiveness.

Low testosterone may indicate severe COVID-19 in men.

TMPRSS2 affects COVID-19 severity and treatment options.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Some early COVID-19 mutations in patients predicted future common virus mutations.

New compounds effective against SARS-CoV-2 variants were identified using a rapid testing method with human lung cells.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

Long COVID is a big health problem needing more research and better treatments.

Long COVID causes lasting symptoms in many body systems, needing more research for better treatments.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Genetic differences affect how people respond to COVID-19.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

The pandemic has pushed dermatology education and care to adopt digital solutions, which are effective and likely to continue post-pandemic.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

The XBB lineage of the Omicron variant spread rapidly in Southeastern Wisconsin.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Natural products like flavonoids and phenolics may help treat or prevent COVID-19.